Motexafin Gadolinium

Motexafin Gadolinium Uses, Dosage, Side Effects, Food Interaction and all others data.

Motexafin Gadolinium is studied in the treatment of cancer by Pharmacyclics. It may make tumor cells more sensitive to radiation therapy, improve tumor images using magnetic resonance imaging (MRI), and kill cancer cells. It belongs to the family of drugs called metalloporphyrin complexes. Also called gadolinium texaphyrin.

Trade Name Motexafin Gadolinium
Generic Motexafin gadolinium
Motexafin gadolinium Other Names Gadolinium texaphyrin, Motexafin gadolinium
Type
Formula C52H72GdN5O14
Weight Average: 1148.4
Monoisotopic: 1148.43167757
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Motexafin Gadolinium
Motexafin Gadolinium

Uses

Investigated for use/treatment in brain cancer, cancer/tumors (unspecified), lung cancer, and lymphoma (non-hodgkin's).

How Motexafin Gadolinium works

Motexafin Gadolinium (Xcytrin) is Pharmacyclics' most advanced anti-cancer product candidate, a small-molecule drug with a novel mechanism of action. Xcytrin accumulates selectively in cancer cells due to their increased rates of metabolism. Once inside the cell, Xcytrin induces apoptosis (programmed cell death) by disrupting redox-dependent pathways. Xcytrin inhibits the enzyme thioredoxin reductase, which is a tumor growth promoter. This mechanism provides the opportunity to use Xcytrin in a wide range of cancers. Xcytrin is paramagnetic, and therefore is detectable by magnetic resonance imaging (MRI), allowing the visualization of the drug in tumors.

Innovators Monograph

You find simplified version here Motexafin Gadolinium

*** Taking medicines without doctor's advice can cause long-term problems.
Share